What FDC does

FDC Limited is an Indian pharmaceutical company founded in 1936 and headquartered in Aurangabad, India, publicly traded on the Bombay Stock Exchange (ticker: FDC). The company is ranked among India's top 25 pharmaceutical companies and operates across two principal product lines: Electral, an Oral Rehydration Solution (ORS) holding over 50% market share in India's ORS segment, and Enerzal, an energy drink competing in the Rs 1,500 crore energy drinks category. FDC generates revenue primarily through the manufacture and sale of branded pharmaceutical formulations and consumer health products distributed through traditional pharmaceutical distribution networks.

The company's commercial operations are anchored by a field force of 5,000+ users deployed across 11 divisions, managing a network of more than 8 lakh doctors through the SANeForce SFA platform (in partnership since 2018). The platform provides selfie-based attendance, geo-tagging, unified doctor identification, and expense management, with vendor-side development of AI, WhatsApp, and event management modules underway. FDC's FY2026 sales reached Rs 2,170.93 crore with consolidated net profit of Rs 281.42 crore; Q4 FY2026 showed 18.89% YoY sales growth and a 167.39% YoY net profit increase, with operating margin expanding to 18.19% from 10.97%.

FDC's business model is built on branded consumer pharmaceuticals distributed through a domestic field force and traditional pharma channels, with no disclosed international footprint beyond India. The company is currently navigating two material external developments: the FSSAI's October 2025 ban on 'ORS' labelling for non-WHO-compliant beverages (which contracted the ORS market by 26% in March 2026), and an ongoing trademark infringement suit in the Delhi High Court against Johnson & Johnson/Kenvue over the eRZL electrolyte drink that allegedly infringes on FDC's Enerzal brand.

Name

FDC

Legal name

FDC Limited

Website

https://fdcindia.com

Company type

Public

Founded year

1936

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

FDC Limited is a publicly traded Indian pharmaceutical company (BSE: FDC) founded in 1936, best known for Electral, which holds over 50% of India's ORS market, and the Enerzal energy drink brand, serving consumers through a field force covering 8 lakh+ doctors across India.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Beverage Manufacturing (3121), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834), Beverages (2080)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Functional Beverages (Vitamins, Probiotics, Nootropics, etc.) (CRADAHAL), Medical & Clinical Nutrition Beverage Production (Oral Nutritional Supplements) (AFAFAFAJ)

Keywords

• Pharmaceutical manufacturing
• Oral rehydration solutions
• Prescription pharmaceuticals
• Consumer health products
• Energy drink formulations

Headquarters

HQ city

Chhatrapati Sambhaji Nagar

HQ country

India

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Marketing or Sales, Supply Chain, Technology or R&D

Revenue model

1. Pharmaceutical products: FDC Limited generates revenue through the manufacturing and sale of pharmaceutical products including oral rehydration solutions (ORS), with its Electral brand holding over 50% market share in India's ORS market, as well as other pharmaceutical formulations and consumer health products like the Enerzal energy drink.

Distribution channels1 record

Marketing channels1 record

Core offering

FDC Limited manufactures and sells pharmaceutical formulations with two flagship consumer-facing brands: Electral, the market-leading oral rehydration solution (ORS) brand in India with over 50% market share, and Enerzal, a competing energy drink in the Rs 1,500 crore energy drinks segment. The company distributes these and other general pharmaceutical products via traditional pharmaceutical distribution networks and a large direct field force organized across 11 divisions that engages a network of more than 8 lakh doctors in India.

Product overview

FDC is one of India's top 25 pharmaceutical companies with two primary consumer-facing products: Electral (Oral Rehydration Solution) and Enerzal (energy drink). Electral dominates the ORS market with over 50% market share, while Enerzal competes in the ₹1,500 crore energy drinks segment. FDC operates across 11 divisions managing a network of more than 8 lakh doctors through field force operations.

Differentiator

Problem solved

Functional benefit

Products and services

• Electral Electral is FDC's Oral Rehydration Solution (ORS) brand and is the market leader in India's ORS segment, historically holding over 50% market share. It is used to treat dehydration and is targeted at healthcare providers and consumers via pharmaceutical distribution and the FDC field force network.
• Enerzal Enerzal is FDC's energy drink brand, competing in India's Rs 1,500 crore energy drinks segment. The brand is the subject of a trademark lawsuit FDC filed in the Delhi High Court against Johnson & Johnson/Kenvue's eRZL electrolyte drink over phonetic similarity. Enerzal is targeted at consumers via pharmaceutical and retail distribution.

Quantifiable outcome

• Operating profit margin improved to 18.19% from 10.97% year-over-year in Q4 FY2026
• +2 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• SANeForcecoreTechnology or Integration · 1 January 2018FDC partnered with SANeForce, a Pharma SFA software provider, for field force automation. The six-year partnership (since 2018) has deployed over 5,000 field force users across 11 divisions managing a network of over 8 lakh doctors. Features include selfie-based attendance, geo-tagging, unified doctor identification, and expense management. SANeForce is developing AI integration, WhatsApp communication, and event management modules to further enhance doctor engagement and rep efficiency.

Scale indicators9 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Cipla: One of India's largest branded pharmaceutical manufacturers, with a comparable portfolio of formulations sold through an extensive field force into the Indian domestic market. Directly comparable as an Indian branded-pharma peer of similar scale and go-to-market model.
• Mankind Pharma: Fast-growing Indian branded formulations company with strong OTC and consumer health adjacencies (including OTC/electrolyte categories). Closely comparable to FDC in product mix, domestic field force intensity, and consumer-pharma crossover.
• Alkem Laboratories: Indian branded pharmaceutical company with a similar domestic-focused formulations portfolio and strong primary-care franchise. Comparable in scale, channel mix, and therapeutic-area breadth to FDC.
• Lupin: Major Indian pharmaceutical manufacturer with a sizable branded formulations business in India across primary and specialty care. Comparable in domestic branded-pharma orientation and field force distribution.

Emerging players

• TTK Healthcare: Indian healthcare company with presence in OTC and consumer health products, including electrolyte/ORS-adjacent categories. A relevant niche competitor to FDC in the ORS/electrolyte space where Electral competes.
• Dabur India: Leading Indian consumer health and Ayurvedic products company that also plays in OTC health drinks and electrolytes (e.g., Glucon-D). Comparable to FDC on the consumer health/electrolyte beverage side, especially for Enerzal.
• Himalaya Drug Company: Indian company combining pharmaceutical/OTC and consumer health products with strong domestic distribution. Comparable to FDC's consumer-pharma crossover positioning, especially in OTC and wellness adjacencies.

Broad incumbents

• Sun Pharmaceutical: India's largest pharmaceutical company with a broad branded and specialty portfolio. A larger, broader incumbent in the same Indian pharma space; comparable on geography and channel, but with much wider therapeutic and international reach.
• Dr. Reddy's Laboratories: Large Indian pharmaceutical company with significant branded generics in India. Comparable in domestic market orientation and pharmaceutical manufacturing, though materially larger and more diversified globally.

Others

• Manforce/Godrej Consumer Products (consumer health arm): Large Indian consumer products company with health and OTC adjacencies. Adjacent comparison for FDC's consumer-facing health brand strategy, particularly relevant to the Enerzal energy drink positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FDC